S. Wong, O. Witte (2004)
The BCR-ABL story: bench to bedside and back.Annual review of immunology, 22
C. Sawyers (1993)
The role of myc in transformation by BCR-ABL.Leukemia & lymphoma, 11 Suppl 1
A. Elmaagacli, Dietrich Beelen, Bertram Opalka, Siegfried Seeber, U. Schaefer (2000)
The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stageAnnals of Hematology, 79
Michael Harris, B. Ozpolat, Fadi Abdi, Sheng Gu, A. Legler, K. Mawuenyega, M. Tírado-Gómez, G. Lopez-Berestein, Xian Chen (2004)
Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia.Blood, 104 5
S. Chu, Melissa Holtz, Mamta Gupta, R. Bhatia (2004)
BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells.Blood, 103 8
S. Tenenbaum, P. Lager, Craig Carson, J. Keene (2002)
Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.Methods, 26 2
C. Jamieson, L. Ailles, S. Dylla, M. Muijtjens, Carol Jones, J. Zehnder, J. Gotlib, Kevin Li, M. Manz, A. Keating, C. Sawyers, I. Weissman (2004)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.The New England journal of medicine, 351 7
W. Michael, P. Eder, G. Dreyfuss (1997)
The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K proteinThe EMBO Journal, 16
Min‐ho Lee, S. Mori, P. Raychaudhuri (1996)
trans-Activation by the hnRNP K Protein Involves an Increase in RNA Synthesis from the Reporter Genes (*)The Journal of Biological Chemistry, 271
C. Sawyers, Wendy Callahan, O. Witte (1992)
Dominant negative MYC blocks transformation by ABL oncogenesCell, 70
Melo Jv (1996)
The molecular biology of chronic myeloid leukaemia.Leukemia, 10
S. Xie, Hui-Kuan Lin, T. Sun, R. Arlinghaus (2002)
Jak2 is involved in c-Myc induction by Bcr-AblOncogene, 21
A. Ostareck-Lederer, D. Ostareck, C. Cans, G. Neubauer, K. Bomsztyk, G. Superti-Furga, M. Hentze (2002)
c-Src-Mediated Phosphorylation of hnRNP K Drives Translational Activation of Specifically Silenced mRNAsMolecular and Cellular Biology, 22
A. Eisbruch, M. Blick, M. Evinger-Hodges, M. Beran, B. Andersson, J. Gutterman, R. Kurzrock (1988)
Effect of differentiation‐inducing agents on oncogene expression in a chronic myelogenous leukemia cell lineCancer, 62
K. Bomsztyk, O. Denisenko, J. Ostrowski (2004)
hnRNP K: One protein multiple processesBioEssays, 26
T. Skorski, Malgorzata Nieborowska‐Skorska, Paweł Włodarski, M. Wasik, R. Trotta, P. Kanakaraj, Paolo Salomoni, Mark Antonyak, Robert Martinez, Miroslaw Majewski, Albert Wong, B. Perussia, Bruno Calabretta (1998)
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing.Blood, 91 2
D. Perrotti, V. Cesi, R. Trotta, C. Guerzoni, G. Santilli, K. Campbell, Angela Iervolino, F. Condorelli, C. Gambacorti-Passerini, M. Caligiuri, B. Calabretta (2002)
BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2Nature Genetics, 30
S. Gribble, Alistair Reid, I. Roberts, C. Grace, A. Green, E. Nacheva (2003)
Genomic imbalances in CML blast crisis: 8q24.12–q24.13 Segment identified as a common region of over‐representationGenes, 37
X. Bustelo, K. Suen, W. Michael, G. Dreyfuss, M. Barbacid (1995)
Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteinsMolecular and Cellular Biology, 15
R. Arlinghaus, T. Sun (2004)
Signal transduction pathways in Bcr-Abl transformed cells.Cancer treatment and research, 119
H. Habelhah, K. Shah, Lan Huang, A. Ostareck-Lederer, Alma Burlingame, K. Shokat, M. Hentze, Z. Ronai (2001)
ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translationNature Cell Biology, 3
R. Trotta, T. Vignudelli, O. Candini, R. Intine, L. Pecorari, C. Guerzoni, G. Santilli, M. Byrom, S. Goldoni, L. Ford, M. Caligiuri, R. Maraia, D. Perrotti, B. Calabretta (2003)
BCR/ABL activates mdm2 mRNA translation via the La antigen.Cancer cell, 3 2
D. Schullery, J. Ostrowski, O. Denisenko, L. Stempka, M. Shnyreva, Hideaki Suzuki, M. Gschwendt, K. Bomsztyk (1999)
Regulated Interaction of Protein Kinase Cδ with the Heterogeneous Nuclear Ribonucleoprotein K Protein*The Journal of Biological Chemistry, 274
D. Perrotti, S. Bonatti, R. Trotta, R. Martinez, T. Skorski, P. Salomoni, E. Grassilli, R. Iozzo, D. Cooper, B. Calabretta (1998)
TLS/FUS, a pro‐oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL‐mediated leukemogenesisThe EMBO Journal, 17
V. Gopal, P. Kadam, H. Preisler, B. Hulette, Yaqin Li, P. Steele, Jed Freeman, S. Banavali (1992)
Abnormal regulation of the myc gene in myeloid leukemiaMedical Oncology and Tumor Pharmacotherapy, 9
M. Deininger, J. Goldman, J. Melo (2000)
The molecular biology of chronic myeloid leukemia.Blood, 96 10
D. Barnes, B. Schultheis, Simisade Adedeji, J. Melo (2005)
Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemiaOncogene, 24
T. Skorski, Malgorzata Nieborowska‐Skorska, Paweł Włodarski, Danilo Perrotti, Robert Martinez, M. Wasik, B. Calabretta (1996)
Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.Proceedings of the National Academy of Sciences of the United States of America, 93 23
K. Nagano, J. Masters, A. Akpan, A. Yang, S. Corless, C. Wood, C. Hastie, M. Zvelebil, R. Cramer, S. Naaby‐Hansen (2004)
Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferonsOncogene, 23
Stephen Taylor, D. Shalloway (1994)
An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosisNature, 368
H. Preisler, H. Sato, P. Yang, M. Wilson, C. Kaufman, R. Watt (1988)
Assessment of c-myc expression in individual leukemic cells.Leukemia research, 12 6
D. Cortez, L. Kadlec, A. Pendergast (1995)
Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosisMolecular and Cellular Biology, 15
A. Makeyev, S. Liebhaber (2002)
The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms.RNA, 8 3
B. Calabretta, D. Perrotti (2004)
The biology of CML blast crisis.Blood, 103 11
M. Karasawa, K. Okamoto, T. Maehara, N. Tsukamoto, K. Morita, T. Naruse, M. Omine (1996)
Detection of c-myc oncogene amplification in a CML blastic phase patient with double minute chromosomes.Leukemia research, 20 1
A. Gaiger, T. Henn, E. Hoerth, K. Geissler, G. Mitterbauer, T. Maier-Dobersberger, H. Greinix, C. Mannhalter, O. Haas, K. Lechner, T. Lion (1995)
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.Blood, 86 6
M. Mandal, R. Vadlamudi, D. Nguyen, R. Wang, Luís Costa, R. Bagheri-Yarmand, J. Mendelsohn, Rakesh Kumar (2001)
Growth Factors Regulate Heterogeneous Nuclear Ribonucleoprotein K Expression and Function*The Journal of Biological Chemistry, 276
A. Urbani, J. Poland, S. Bernardini, L. Bellincampi, Antonino Biroccio, M. Schnölzer, P. Sinha, G. Federici (2005)
A proteomic investigation into etoposide chemo‐resistance of neuroblastoma cell linesPROTEOMICS, 5
Chi Ly, A. Arechiga, J. Melo, C. Walsh, S. Ong (2003)
Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin.Cancer research, 63 18
Maya Groysman, M. Nagano, B. Shaanan, S. Katzav (1998)
Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformationOncogene, 17
A. Gingras, B. Raught, N. Sonenberg (2004)
mTOR signaling to translation.Current topics in microbiology and immunology, 279
T. Skorski, M. Nieborowska-Skorska, P. Włodarski, G. Zon, R. Iozzo, B. Calabretta (1996)
Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice.Blood, 88 3
Shaoguang Li, A. Couvillon, B. Brasher, R. Etten (2001)
Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signalingThe EMBO Journal, 20
Joanne Evans, S. Mitchell, K. Spriggs, J. Ostrowski, K. Bomsztyk, Dirk Ostarek, A. Willis (2003)
Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivoOncogene, 22
E. Michelotti, G. Michelotti, A. Aronsohn, David Levens (1996)
Heterogeneous nuclear ribonucleoprotein K is a transcription factorMolecular and Cellular Biology, 16
M. Blick, P. Romero, M. Talpaz, R. Kurzrock, M. Shtalrid, B. Andersson, J. Trujillo, M. Beran, J. Gutterman (1987)
Molecular characteristics of chronic myelogenous leukemia in blast crisis.Cancer genetics and cytogenetics, 27 2
P. Neviani, R. Santhanam, R. Trotta, M. Notari, B. Blaser, Shujun Liu, H. Mao, J. Chang, A. Galietta, Ashwin Uttam, D. Roy, M. Valtieri, Rebecca Bruner-Klisovic, M. Caligiuri, C. Bloomfield, G. Marcucci, D. Perrotti (2005)
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.Cancer cell, 8 5
A. Cristofano, M. Niki, Mingming Zhao, F. Karnell, B. Clarkson, W. Pear, L. Aelst, P. Pandolfi (2001)
P62dok, a Negative Regulator of Ras and Mitogen-Activated Protein Kinase (Mapk) Activity, Opposes Leukemogenesis by P210bcr-ablThe Journal of Experimental Medicine, 194
T. Skorski, Malgorzata Nieborowska‐Skorska, C. Szczylik, P. Kanakaraj, Danilo Perrotti, Gerald Zon, A. Gewirtz, B. Perussia, Bruno Calabretta (1995)
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.Cancer research, 55 11
M. Cheng, Demin Wang, M. Roussel (1999)
Expression of c-Myc in Response to Colony-stimulating Factor-1 Requires Mitogen-activated Protein Kinase Kinase-1*The Journal of Biological Chemistry, 274
C. Sawyers (1999)
Chronic myeloid leukemia.The New England journal of medicine, 340 17
D. Perrotti, Francesco Turturro, P. Neviani (2005)
BCR/ABL, mRNA translation and apoptosisCell Death and Differentiation, 12
Angela Iervolino, G. Santilli, R. Trotta, C. Guerzoni, V. Cesi, A. Bergamaschi, C. Gambacorti-Passerini, B. Calabretta, D. Perrotti (2002)
hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL LeukemogenesisMolecular and Cellular Biology, 22
D. Cortez, G. Reuther, A. Pendergast (1997)
The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cellsOncogene, 15
K. Ohmine, J. Ota, M. Ueda, S. Ueno, Koji Yoshida, Y. Yamashita, K. Kirito, S. Imagawa, Yuichi Nakamura, Kenji Saito, M. Akutsu, K. Mitani, Y. Kano, N. Komatsu, K. Ozawa, H. Mano (2001)
Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cellsOncogene, 20
U. Matulonis, Ravi Salgia, K. Okuda, B. Druker, James Griffin (1993)
Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.Experimental hematology, 21 11
Blood – Unpaywall
Published: Nov 18, 2005
Access the full text.
Sign up today, get DeepDyve free for 14 days.